The last of six COVID monoclonal antibody treatments has lost its federal authorization because, like the others, it no longer works against the newest Omicron subvariants.
Dec 5, 2022
0
23
Patients with cancer and a weakened immune system who are treated with immunotherapies tend to fare far worse from COVID-19 than those who haven't received such therapies in the three months before their COVID diagnosis, ...
Nov 3, 2022
0
39
Georgios Sotiriou, principal researcher at the Department of Microbiology, Tumor and Cell Biology, and his colleagues have developed a durable coating for medical devices which is activated by light, providing on-demand disinfection.
Nov 2, 2022
0
5
A panel of investigational monoclonal antibodies (mAbs) targeting different sites of the Epstein-Barr virus (EBV) blocked infection when tested in human cells in a laboratory setting. Moreover, one of the experimental mAbs ...
Oct 27, 2022
0
34
An international team of researchers has developed a way to modify the CAR T engineering process to create cells that can assist in fighting fungal infections in the lungs. In their paper published in the journal Science ...
Do patients with prolonged infections contribute to the emergence of new SARS-CoV-2 variants? A research team from the Leibniz Institute of Virology (LIV) and the University Medical Center Hamburg-Eppendorf (UKE) has investigated ...
Aug 17, 2022
0
75
Two broadly neutralizing antibodies show great promise to provide long-acting immunity against COVID-19 in immunocompromised populations according to a paper published June 15 in the Journal of Experimental Medicine (JEM). ...
Jun 15, 2022
0
5
According to a new study published today in Blood Advances, frailty assessments, a type of geriatric exam essential to predicting health outcomes in older adults with cancer, are both safe and feasible when conducted virtually. ...
May 26, 2022
0
3
The longest known COVID-19 infection is described by UK researchers at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Lisbon, Portugal, (23-26 April).
Apr 22, 2022
0
24
CoVac-1, a new vaccine against SARS-CoV-2, induced T-cell immune responses in 93 percent of patients with B-cell deficiencies, including many patients with leukemia and lymphoma, according to results presented at the AACR ...
Apr 12, 2022
0
6
